Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Roger Herzig"'
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 1. Multivariate analysis of late relapse, transplant-related mortality, overall survival after HCT for each disease (AML, ALL, CML, MDS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8b6bb0ec143b555d4baa55cd9d07bc
https://doi.org/10.1158/1078-0432.22459019.v1
https://doi.org/10.1158/1078-0432.22459019.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Purpose: Malignancy relapse remains a major obstacle for successful allogeneic hematopoietic cell transplantation (HCT). Chronic graft-versus-host disease (cGVHD) is associated with fewer relapses. However, when studying effects of cGVHD on relapse,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1562e3003d7ce693a7bac43e825778d3
https://doi.org/10.1158/1078-0432.c.6524114.v1
https://doi.org/10.1158/1078-0432.c.6524114.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 4. Multivariate analysis showing impact of cGVHD characteristics on treatment related mortality, disease free survival, overall survival in patients with AML, ALL, MDS who developed cGVHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96a29a4f89ff9eb180a33441e9c479c0
https://doi.org/10.1158/1078-0432.22459010.v1
https://doi.org/10.1158/1078-0432.22459010.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 2. Multivariate analysis showing impact of cGVHD characteristics in CML patients on relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd075a41ef6607b9609e016590c0139a
https://doi.org/10.1158/1078-0432.22459016
https://doi.org/10.1158/1078-0432.22459016
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 3. Multivariate analysis showing impact of cGVHD characteristics on treatment related mortality, disease free survival and overall survival in patients with CML who developed cGVHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f3f162450909dadf1eee374d2d4530
https://doi.org/10.1158/1078-0432.22459013.v1
https://doi.org/10.1158/1078-0432.22459013.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Figure 1. Cumulative incidence of cGVHD, relapse and death in patients with AML, ALL, CML, MDS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff0a47fd6e908c56333b879a03134c9
https://doi.org/10.1158/1078-0432.22459022.v1
https://doi.org/10.1158/1078-0432.22459022.v1
Publikováno v:
Medical Decision Making. 11:1-8
There are more than 20 drug combinations in use for the treatment of diffuse large-cell non- Hodgkin's lymphoma (NHL). New treatments have been developed without prior comparison in clinical trials. The authors devised a Markov-process model to compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0005f9a8453d58dd51d59a424a6cb7
https://doi.org/10.1177/0272989x9101100101
https://doi.org/10.1177/0272989x9101100101
